Atsushi Sakuraba

6.0k total citations
153 papers, 4.2k citations indexed

About

Atsushi Sakuraba is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Atsushi Sakuraba has authored 153 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Genetics, 84 papers in Epidemiology and 42 papers in Surgery. Recurrent topics in Atsushi Sakuraba's work include Inflammatory Bowel Disease (98 papers), Microscopic Colitis (62 papers) and Autoimmune and Inflammatory Disorders (24 papers). Atsushi Sakuraba is often cited by papers focused on Inflammatory Bowel Disease (98 papers), Microscopic Colitis (62 papers) and Autoimmune and Inflammatory Disorders (24 papers). Atsushi Sakuraba collaborates with scholars based in United States, Japan and Israel. Atsushi Sakuraba's co-authors include Dejan Micić, Toshifumi Hibi∥, Toshiro Sato, Yuga Komaki, Fukiko Komaki, David T. Rubin, Shintaro Akiyama, Nobuhiko Kamada, Haruhiko Ogata and Russell D. Cohen and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and PLoS ONE.

In The Last Decade

Atsushi Sakuraba

143 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Atsushi Sakuraba United States 33 2.0k 1.6k 1.2k 892 657 153 4.2k
Tim Raine United Kingdom 29 2.8k 1.4× 2.0k 1.2× 1.4k 1.1× 1.0k 1.1× 344 0.5× 97 4.9k
Dirk J. de Jong Netherlands 39 2.0k 1.0× 1.6k 1.0× 1.5k 1.3× 970 1.1× 428 0.7× 119 4.4k
Tariq Ahmad United Kingdom 34 2.9k 1.5× 1.9k 1.2× 1.6k 1.4× 1.4k 1.6× 313 0.5× 131 5.2k
Alfredo Papa Italy 36 1.9k 0.9× 1.4k 0.9× 673 0.6× 1.4k 1.6× 279 0.4× 161 3.9k
Jens Frederik Dahlerup Denmark 36 1.3k 0.6× 1.5k 0.9× 723 0.6× 1.0k 1.1× 807 1.2× 150 4.6k
Vera Ballet Belgium 26 2.2k 1.1× 1.6k 1.0× 955 0.8× 835 0.9× 516 0.8× 76 4.1k
Stuart Bloom United Kingdom 27 2.4k 1.2× 1.6k 1.0× 1.2k 1.0× 1.3k 1.4× 235 0.4× 114 4.4k
Eugeni Domènech Spain 36 2.5k 1.2× 2.2k 1.4× 598 0.5× 1.2k 1.4× 296 0.5× 222 4.0k
Frank Seibold Switzerland 37 2.4k 1.2× 2.0k 1.2× 1.2k 1.0× 1.3k 1.5× 296 0.5× 112 4.5k
Charlie W. Lees United Kingdom 29 2.5k 1.2× 1.7k 1.1× 752 0.6× 1.0k 1.2× 271 0.4× 133 4.0k

Countries citing papers authored by Atsushi Sakuraba

Since Specialization
Citations

This map shows the geographic impact of Atsushi Sakuraba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Sakuraba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Sakuraba more than expected).

Fields of papers citing papers by Atsushi Sakuraba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Sakuraba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Sakuraba. The network helps show where Atsushi Sakuraba may publish in the future.

Co-authorship network of co-authors of Atsushi Sakuraba

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Sakuraba. A scholar is included among the top collaborators of Atsushi Sakuraba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Sakuraba. Atsushi Sakuraba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cleveland, Noa Krugliak, D Choi, Nicole Garcia, et al.. (2023). P724 Upadacitinib is Effective and Safe in Tofacitinib-Experienced Patients with Ulcerative Colitis: A Prospective Real-World Experience. Journal of Crohn s and Colitis. 17(Supplement_1). i854–i856. 4 indexed citations
3.
Hui, Zhang, et al.. (2023). Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease. Annals of Medicine. 55(1). 2198775–2198775. 10 indexed citations
4.
Choi, D, Nicole Garcia, Nathaniel A. Cohen, et al.. (2023). P580 Upadacitinib is effective and safe for Ulcerative Colitis: prospective real-world experience. Journal of Crohn s and Colitis. 17(Supplement_1). i707–i709.
5.
Wang, Jingzhou, et al.. (2021). Covid-19 Reinfection: A Rapid Systematic Review of Case Reports and Case Series. Journal of Investigative Medicine. 69(6). 1253–1255. 76 indexed citations
6.
Keswani, Rajesh N., et al.. (2021). Bariatric Bypass Surgery Is a Risk Factor for Incomplete Colonoscopy Preparation. Digestive Diseases and Sciences. 67(7). 3185–3191.
7.
Buisson, Anthony, Lisa Cannon, Konstantin Umanskiy, et al.. (2021). Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn’s disease. Intestinal Research. 20(3). 303–312. 10 indexed citations
8.
Cohen, Nathaniel A., Cindy Traboulsi, Shruti Patel, et al.. (2021). P455 Tofacitinib Therapy is Effective for Arthralgias Associated with Active Inflammatory Bowel Disease. Journal of Crohn s and Colitis. 15(Supplement_1). S450–S450. 1 indexed citations
9.
Ollech, Jacob E., Noam Peleg, Jingzhou Wang, et al.. (2020). Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology. 19(1). 104–110. 65 indexed citations
10.
11.
Yamada, Akihiro, et al.. (2020). Systemic review and network meta-analysis: Prophylactic antibiotic therapy for spontaneous bacterial peritonitis. World Journal of Hepatology. 12(5). 239–252. 13 indexed citations
12.
Tomizawa, Yutaka, Akiko Tanaka, Hiroto Kitahara, et al.. (2018). Preoperative Right-Sided Cardiac Congestion Is Associated with Gastrointestinal Bleeding in Patients with Continuous-Flow Left Ventricular Assist Devices. Digestive Diseases and Sciences. 63(6). 1518–1524. 10 indexed citations
13.
Komaki, Fukiko, Yuga Komaki, Dejan Micić, Akio Ido, & Atsushi Sakuraba. (2016). Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis. Journal of Autoimmunity. 76. 38–52. 56 indexed citations
14.
Christensen, Britt, Ruben J. Colman, Andrés Yarur, et al.. (2015). Tu1351 Crohn's Disease Patients Currently or Previously on Natalizumab Can Be Safely and Effectively Switched to Vedolizumab. Gastroenterology. 148(4). S–866. 1 indexed citations
15.
Tomizawa, Yutaka, Atsushi Sakuraba, & Joel Pekow. (2014). Parastomal Variceal Bleeding Attributed to Obstructive Pathology Successfully Treated by Percutaneous Variceal Embolization. ACG Case Reports Journal. 1(4). 217–219. 1 indexed citations
16.
Bellaguarda, Emanuelle, Joel Pekow, Russell D. Cohen, David T. Rubin, & Atsushi Sakuraba. (2014). Mo1183 Prevalence of Serum JC Virus Antibody in Refractory Crohn's Disease Patients. Gastroenterology. 146(5). S–580. 1 indexed citations
17.
Hibi∥, Toshifumi, Atsushi Sakuraba, Mamoru Watanabe, et al.. (2013). C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn’s disease. Journal of Gastroenterology. 49(2). 254–262. 50 indexed citations
18.
Naganuma, Makoto, Atsushi Sakuraba, & Toshifumi Hibi∥. (2013). Ulcerative colitis: prevention of relapse. Expert Review of Gastroenterology & Hepatology. 7(4). 341–351. 10 indexed citations
19.
Sakuraba, Atsushi, et al.. (2013). Efficacy and Safety of Medical Therapy for Low Bone Mineral Density in Patients With Inflammatory Bowel Disease: A Meta-analysis and Systematic Review. Clinical Gastroenterology and Hepatology. 12(1). 32–44.e5. 46 indexed citations
20.
Sato, Shigemi, et al.. (1988). A study on extrauterine cancer in uterine cervical smears.. The Journal of the Japanese Society of Clinical Cytology. 27(6). 842–848. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Raine Breakdown of academic impact, for papers by Dirk J. de Jong Breakdown of academic impact, for papers by Tariq Ahmad Breakdown of academic impact, for papers by Alfredo Papa Breakdown of academic impact, for papers by Jens Frederik Dahlerup Breakdown of academic impact, for papers by Vera Ballet Breakdown of academic impact, for papers by Stuart Bloom Breakdown of academic impact, for papers by Eugeni Domènech Breakdown of academic impact, for papers by Frank Seibold Breakdown of academic impact, for papers by Charlie W. Lees
Rankless by CCL
2026